Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 205,782,267 papers from all fields of science
Search
Sign In
Create Free Account
psammaplin A
Known as:
bisprasin
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
3 relations
Broader (2)
Disulfides
Tyrosine
analogs & derivatives
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Triggering of Suicidal Erythrocyte Death by Psammaplin A
Abdulla Al Mamun Bhuyan
,
E. Signoretto
,
F. Lang
Cellular Physiology and Biochemistry
2016
Corpus ID: 12032939
Background/Aims: Psammaplin A, a natural product isolated from marine sponges, triggers apoptosis of tumor cells and is thus…
Expand
2013
2013
Thioester derivatives of the natural product psammaplin A as potent histone deacetylase inhibitors
M. Baud
,
Thomas Leiser
,
+4 authors
M. Fuchter
Beilstein journal of organic chemistry
2013
Corpus ID: 16633304
Summary There has been significant interest in the bioactivity of the natural product psammaplin A, most recently as a potent and…
Expand
2013
2013
Psammaplin A inhibits hepatitis C virus NS3 helicase
K. Salam
,
A. Furuta
,
+9 authors
N. Akimitsu
Journal of Natural Medicines
2013
Corpus ID: 8381138
Hepatitis C virus (HCV) is the causative agent of hepatitis C, a chronic infectious disease that can lead to development of…
Expand
Highly Cited
2008
Highly Cited
2008
A natural histone deacetylase inhibitor, Psammaplin A, induces cell cycle arrest and apoptosis in human endometrial cancer cells.
M. Ahn
,
Jee H Jung
,
Y. Na
,
Hyung Sik Kim
Gynecologic oncology
2008
Corpus ID: 25494464
Highly Cited
2007
Highly Cited
2007
Psammaplin A is a natural prodrug that inhibits class I histone deacetylase
Dong Hoon Kim
,
Jongheon Shin
,
H. Kwon
Experimental & Molecular Medicine
2007
Corpus ID: 8168302
Histone deacetylase (HDAC) has been highlighted as one of key players in tumorigenesis and angiogenesis. Recently, several…
Expand
Highly Cited
2004
Highly Cited
2004
Cytotoxicity of psammaplin A from a two-sponge association may correlate with the inhibition of DNA replication
Ya-hong Jiang
,
Eun-young Ahn
,
+7 authors
Jee H Jung
BMC Cancer
2004
Corpus ID: 16371082
BackgroundSV40 DNA replication system is a very useful tool to understand the mechanism of replication, which is a tightly…
Expand
Review
2003
Review
2003
The discovery of NVP-LAQ824: from concept to clinic.
S. Remiszewski
Current medicinal chemistry
2003
Corpus ID: 20797256
The natural products trapoxin B and trichostatin A, as well as the novel marine natural product psammaplin A (PSMA) were found in…
Expand
Highly Cited
2001
Highly Cited
2001
Combinatorial synthesis through disulfide exchange: discovery of potent psammaplin A type antibacterial agents active against methicillin-resistant Staphylococcus aureus (MRSA).
K. Nicolaou
,
R. Hughes
,
J. Pfefferkorn
,
S. Barluenga
,
A. Roecker
Chemistry
2001
Corpus ID: 8855487
Psammaplin A is a symmetrical bromotyrosine-derived disulfide natural product isolated from the Psammaplysilla sponge, which…
Expand
Highly Cited
1999
Highly Cited
1999
Psammaplin A, a natural bromotyrosine derivative from a sponge, possesses the antibacterial activity against methicillin-resistantStaphylococcus aureus and the DNA gyrase-inhibitory activity
D. Kim
,
I. Lee
,
J. Jung
,
S. Yang
Archives of pharmacal research
1999
Corpus ID: 2331575
Psammaplin A, a natural bromotyrosine derivative from an associated form of two sponges (Poecillastra sp. andJaspis sp.) was…
Expand
Highly Cited
1999
Highly Cited
1999
Psammaplin A, a natural phenolic compound, has inhibitory effect on human topoisomerase II and is cytotoxic to cancer cells.
D. Kim
,
I. Lee
,
J. Jung
,
C. O. Lee
,
S. U. Choi
Anticancer research
1999
Corpus ID: 20922962
We evaluated the topoisomerase II (Topo II) inhibitory activity of psammaplin A (PSA), a naturally occurring biphenolic compound…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
,
Terms of Service
, and
Dataset License
ACCEPT & CONTINUE